Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

AstraZeneca imparts the synthesis of three series of H+/K+-ATPase inhibitors

March 2, 2005

Bayer describes novel PDE9A inhibitors for Alzheimer's disease

March 2, 2005

Eisai scientists disclose the neuroprotective activity of donepezil hydrochloride

March 2, 2005

Novel ALK-5 receptor inhibitors imparted by GSK

March 2, 2005

Chemokine CCR5 receptor activators claimed by Ono

March 2, 2005

Modulators of amyloid beta levels claimed by Neurogenetics for Alzheimer's disease

March 2, 2005

NeuroSearch researchers disclose new chloride channel blocking agents

March 1, 2005

KSP inhibitors claimed by Chiron for the treatment of cancer

March 1, 2005

Bristol-Myers Squibb scientists describe new CCR3 receptor antagonists

March 1, 2005

Dual-action tachykinin receptor antagonists developed at AstraZeneca

March 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...